PetMed Express, Inc.
General ticker "PETS" information:
- Sector: Health Care
- Industry: Medical - Pharmaceuticals
- Capitalization: $52.2M (TTM average)
PetMed Express, Inc. does not follow the US Stock Market performance with the rate: -21.9%.
Estimated limits based on current volatility of 2.3%: low 1.19$, high 1.25$
Factors to consider:
- Total employees count: 189 (+9.2%) as of 2026
- Company does not operate outside US (retrieved using AI)
- Top business risk factors: Regulatory and compliance, Cybersecurity threats, Supply chain disruptions, Acquisition/divestiture risks, Market competition
- Current price 29.8% below estimated low
- Earnings for 3 months up through Q1 are below our estimates
Stock Forecast*
* forecast is subjective and experimental, should not be used for any investment decisions
Long term estimates were made for the period from 2026-03-31 to 2028-03-30
- 2026-03-31 to 2027-03-31 estimated range: [1.68$, 3.55$]
- 2027-03-31 to 2028-03-30 estimated range: [1.69$, 3.53$]
Financial Metrics affecting the PETS estimates:
- Positive: with PPE of -2.1 at the end of fiscal year the price was low
- Negative: negative Operating income
- Positive: 34.41 < Shareholder equity ratio, % of 35.64 <= 42.26
- Positive: Inventory ratio change, % of 0.87 <= 1.34
- Positive: -11.23 < Investing cash flow per share per price, % of -9.61
- Negative: negative Operating cash flow
- Positive: Interest expense per share per price, % of 0 <= 0
- Positive: -0.53 < Industry operating cash flow per share per price (median), % of 0.76
Short-term PETS quotes
Long-term PETS plot with estimates
Financial data
| YTD | 2024-03-31 | 2025-03-31 | 2026-03-31 |
|---|---|---|---|
| Operating Revenue | $274.10MM | $226.97MM | $179.02MM |
| Operating Expenses | $282.26MM | $228.50MM | $210.44MM |
| Operating Income | $-8.16MM | $-1.53MM | $-31.41MM |
| Non-Operating Income | $1.89MM | $0.94MM | $-25.94MM |
| Income(Loss) | $-6.27MM | $-0.59MM | $-57.36MM |
| Taxes | $1.19MM | $5.68MM | $-0.07MM |
| Net Income(Loss)* | $-7.46MM | $-6.27MM | $-57.29MM |
| Stockholders Equity | $96.73MM | $85.13MM | $28.94MM |
| Inventory | $28.56MM | $16.20MM | $13.61MM |
| Assets | $169.88MM | $148.70MM | $81.19MM |
| Operating Cash Flow | $4.32MM | $4.72MM | $-28.39MM |
| Capital expenditure | $4.51MM | $5.11MM | $4.62MM |
| Investing Cash Flow | $-40.67MM | $-5.11MM | $-4.62MM |
| Financing Cash Flow | $-12.44MM | $-0.18MM | $-0.30MM |
| Earnings Per Share** | $-0.37 | $-0.30 | $-2.74 |
* Profit(Loss) attributable to entity.
** EPS are Split Adjusted, recent splits may be reflected with a delay.